In this Supplement
The choice for patients who can return to an active life.
How the hemodynamic effects of TAVR and SAVR impact clinical outcomes.
By Colin M. Barker, MD; Moritz Wyler von Ballmoos, MD; and Michael J. Reardon, MD
Considerations for this minimally invasive approach to treating patients with failed bioprostheses.
By Danny Dvir, MD
The choice of transcatheter heart valve affects hemodynamics in patients with a small aortic annulus.
By Toby Rogers, MD, PhD
A surgeon’s perspective on how device attributes can improve these factors to facilitate good outcomes as the TAVR treatment population expands.